Research Options:

Week of Expected Pricing Pending
Company Name Merrion pharmaceuticals limited
Proposed Ticker MERR
CUSIP 59042R106
Business Description A specialty pharmaceutical company engaged in the development of pharmaceutical products, both independently and in collaboration with other pharmaceutical companies.
Lead Underwriter Punk, Ziegel & Company
Co-Managers Goodbody Stockbrokers, Stanford Group Company
Initial Shares 4000000
Revised Initial Shares N/A
Initial Price $6.00-$7.00
Revised Price N/A
Final Price N/A
Final Ticker N/A

 

 

   
  © 2024 ICE Data Services. All rights reserved.